Home Media News
News February 22, 2026 3 min read
Insights from WHX Dubai: Scaling HealthTech with Purpose

Insights from WHX Dubai: Scaling HealthTech with Purpose

At WHX Dubai, our CEO explored why scaling a HealthTech startup isn’t just about growth—it’s about building responsible AI infrastructure, globally representative data foundations, and long-term trust in healthcare innovation.

P
PAICON
From Data to Diagnostics
Global Cancer Data HealthTech Leadership AI in Oncology
Share:

At WHX Dubai, our CEO & Co-Founder Dr. Manasi A-Ratnaparkhe joined the Visionary Stage for the EmpowHer panel, “The Female Founder’s Journey: Scaling a HealthTech Startup.”

Our CEO at WHX Dubai

The discussion brought together female founders shaping the future of healthcare; sharing not only the realities of scaling innovation in a highly regulated industry, but also the responsibility that comes with building technology for medicine.

Scaling a HealthTech Startup Means Scaling Responsibility

Building a healthtech company is fundamentally different from scaling a conventional tech startup.

In healthcare, growth must go hand in hand with:

  • Scientific rigor

  • Regulatory compliance

  • Clinical validation

  • Long-term trust

During the panel, Manasi reflected on the complexity of scaling at the intersection of AI, real-world data, and oncology. Success in this space is not defined solely by expansion metrics, but by the ability to build infrastructure that enables better medical decisions.

And that infrastructure begins with data.

Why the Future of Healthcare Depends on Stronger Data Foundations

PAICON at WHX Dubai

A central theme of the conversation was the urgent need to modernize healthcare’s data foundations.

Medical data remains fragmented, siloed, and disproportionately concentrated in limited geographies. As a result, large parts of the global population remain underrepresented in the datasets that power today’s AI systems.

If AI in healthcare is to be robust, equitable, and trustworthy, it must reflect global diversity biologically, genetically, and demographically.

Behind every dataset are patients and families whose outcomes depend on the quality of these systems. Scaling responsibly therefore means ensuring that the data used to train AI truly represents the populations it aims to serve.

At PAICON, this belief shapes our mission: connecting globally representative real-world data to AI, and AI back to real clinical impact.

Diverse, harmonized data enables stronger models.
Stronger models drive meaningful insights.
Meaningful insights improve patient outcomes.

When this loop works, healthcare becomes more precise, more equitable, and ultimately more human.

Looking Ahead: Building the Infrastructure for Equitable AI

The conversation at WHX Dubai reinforced a critical message: the future of healthtech leadership is not only about innovation; it is about intention.

Scaling a company in this space means committing to long-term impact. It means investing in data infrastructure that reflects global populations. It means building AI systems that are not only advanced, but responsible and inclusive.

As healthcare continues to evolve, strengthening its data foundations will be one of the most important steps toward better medicine worldwide.

We thank WHX Dubai and the EmpowHer panel organizers for creating a platform to discuss both the opportunities and responsibilities of shaping the next generation of healthcare innovation.

Subscribe to Our Monthly Newsletter

Each month, we will send key data updates, stories from the field, and new research on inclusive oncology AI.